Spinal surgery device firm TranS1 raises $18.3M in stock sale
Medical device company TranS1 (NASDAQ:TSON), which focuses on devices that treat degenerative spinal conditions, has raised about $18.3 million in net proceeds from a stock offering intended to finance clinical trials. The Wilmington, North Carolina-based company priced the stock offering of 6.2 million shares last week. The stock offering follows the May filing of a […]